Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PUMA BIOTECHNOLOGY, INC.

(PBYI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société PUMA BIOTECHNOLOGY, INC.
09/21PUMA BIOTECHNOLOGY : to Present at the Cantor Virtual Global Healthcare Conference
BU
09/07PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
09/07PUMA BIOTECHNOLOGY : to Present at the H.C. Wainwright 23rd Annual Global Investment Confe..
BU
08/06PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
08/05PUMA BIOTECH : Q2 Earnings Snapshot
AQ
08/05PUMA BIOTECHNOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
08/05PUMA BIOTECHNOLOGY : Reports Second Quarter 2021 Financial Results
BU
08/05PUMA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
07/29PUMA BIOTECHNOLOGY : Note Purchase Agreement (Form 8-K)
PU
07/29PUMA BIOTECHNOLOGY, INC. : Entry into a Material Definitive Agreement, Creation of a Direc..
AQ
07/26PUMA BIOTECHNOLOGY : Secures $125 Million Note Purchase by Athyrium Capital
BU
07/22PUMA BIOTECHNOLOGY : to Host Conference Call to Discuss Second Quarter Financial Results
BU
07/14PUMA BIOTECHNOLOGY : Departure of Directors or Principal Officers; Election of Directors; ..
PU
07/14PUMA BIOTECHNOLOGY, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
07/02PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
07/01PUMA BIOTECHNOLOGY : FDA Approves Dose Escalation Label Update for Puma Biotechnology's NE..
BU
06/25PUMA BIOTECHNOLOGY, INC. : Other Events (form 8-K)
AQ
06/17PUMA BIOTECHNOLOGY, INC. : Change in Directors or Principal Officers, Submission of Matter..
AQ
06/04PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
06/04PUMA BIOTECHNOLOGY : Presents Data from the EGFR Exon 18-mutant NSCLC Cohort of the Phase ..
BU
06/04PUMA BIOTECHNOLOGY : Presents Data Comparing Findings from the Phase II CONTROL Trial with..
BU
06/04PUMA BIOTECHNOLOGY : Presents Data from the Phase III ExteNET Trial in Early Stage HER2-Po..
BU
05/19PUMA BIOTECHNOLOGY : Announces Publication of Abstracts on Neratinib for the 2021 ASCO Ann..
BU
05/06PUMA BIOTECH : Q1 Earnings Snapshot
AQ
05/06PUMA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
05/06PUMA BIOTECHNOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
05/06PUMA BIOTECHNOLOGY : Reports First Quarter 2021 Financial Results
BU
05/04PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
04/22PUMA BIOTECHNOLOGY : to Host Conference Call to Discuss First Quarter Financial Results
BU
04/14PUMA BIOTECHNOLOGY : 2021 Annual Meeting Notice
PU
04/13PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
03/29PUMA BIOTECHNOLOGY, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
03/08PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
03/04PUMA BIOTECHNOLOGY : to Present at the Barclays Global Healthcare Conference
BU
03/02PUMA BIOTECHNOLOGY : to Present at the H.C. Wainwright Global Life Sciences Conference
BU
03/01PUMA BIOTECHNOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
02/26PUMA BIOTECHNOLOGY : and Pierre Fabre Amend NERLYNX License Agreement to Include Greater C..
AQ
02/26PUMA BIOTECHNOLOGY : 4Q-2020 Results Call – Commercial Update
PU
02/25PUMA BIOTECH : 4Q Earnings Snapshot
AQ
02/25PUMA BIOTECHNOLOGY : and Pierre Fabre Amend NERLYNX® License Agreement to Include Greater ..
BU
02/25PUMA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
02/25PUMA BIOTECHNOLOGY : Reports Fourth Quarter and Full Year Financial Results
BU
02/23PUMA BIOTECHNOLOGY, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
02/20PUMA BIOTECHNOLOGY : Tigerlily Foundation Launches a New Web Series, BREATHE Tv on Faceboo..
AQ
02/11PUMA BIOTECHNOLOGY : to Host Conference Call to Discuss Fourth Quarter and Full Year 2020 ..
BU
02/11PUMA BIOTECHNOLOGY, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
02/10PUMA BIOTECHNOLOGY : Reports Inducement Awards under Nasdaq Listing Rule 5635(4)
AQ
02/09PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
02/01PUMA BIOTECHNOLOGY : Presents Interim Results from the Phase II SUMMIT Trial of Neratinib ..
AQ
01/29PUMA BIOTECHNOLOGY : Presents Interim Results from the Phase II SUMMIT Trial of Neratinib ..
BU
01/19PUMA BIOTECHNOLOGY : to Present at the B. Riley Oncology Investor Conference
BU
01/18PUMA BIOTECHNOLOGY : Presents Interim Results from the Biliary Tract Cancers Cohort of the..
AQ
01/15PUMA BIOTECHNOLOGY : Presents Interim Results from the Biliary Tract Cancers Cohort of the..
BU
01/05PUMA BIOTECHNOLOGY : to Present at the J.P. Morgan Healthcare Conference
BU
01/04PUMA BIOTECHNOLOGY : to Present at the H.C. Wainwright VIRTUAL BioConnect Conference
BU
2020PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
2020PUMA BIOTECHNOLOGY : Presents Efficacy and Safety Outcomes from the Phase III NALA Trial a..
BU
2020PUMA BIOTECHNOLOGY : Presents Final Overall Survival Analysis from the Phase III ExteNET T..
BU
2020PUMA BIOTECHNOLOGY : Presents Updated Results from the Phase II SUMMIT Trial of Neratinib ..
BU
2020PUMA BIOTECHNOLOGY, INC. : Prevails Before European Patent Office Board of Appeals in Deci..
BU
2020PUMA BIOTECHNOLOGY : to Present Neratinib Data at the San Antonio Breast Cancer Symposium ..
BU
2020PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
2020PUMA BIOTECHNOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
2020PUMA BIOTECH : 3Q Earnings Snapshot
AQ
2020PUMA BIOTECHNOLOGY : Announces Interim Results from the Phase II SUMMIT Trial of Neratinib..
BU
2020PUMA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Other Events, Fi..
AQ
2020PUMA BIOTECHNOLOGY : Reports Third Quarter 2020 Financial Results
BU
2020PUMA BIOTECHNOLOGY : to Present at the Credit Suisse 29th Annual Virtual Healthcare Confer..
BU
2020PUMA BIOTECHNOLOGY : to Host Conference Call to Discuss Third Quarter Financial Results
BU
2020PUMA BIOTECHNOLOGY : Announces Publication of Overall Survival Results from Phase III Exte..
BU
2020PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
2020PUMA BIOTECHNOLOGY : to Present at the H.C. Wainwright 22nd Annual Global Investment Confe..
BU
2020PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
2020PUMA BIOTECHNOLOGY : Announces Publication of Interim Results of Phase II CONTROL Trial in..
BU
2020PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
1  2  3  4Next
Upcoming event on PUMA BIOTECHNOLOGY, INC.
11/10/21